International audienceIn eukaryots the protein N-glycosylation processes starts in the endoplasmic reticulum and continues with the maturation steps in the Golgi apparatus (Fig. 1). In C. reinhardtii, the maturation steps results in glycans N-linked to proteins ranging from Man5GlcNAc2 to Man3GlcNAc2 and carrying one or two xylose residues (Fig. 1) (Vanier et al. 2017, Lucas/Dumontier et al. 2018). Nowadays, little information is available regarding the xylosylation in C. reinhardtii. This study aimed at characterizing the molecular actors involved in xylosylation process using complementary analysis, such as Western blot, nanoliquid chromatography coupled to electrospray mass spectrometry (nanoLC-ESI-MS), multistage tandem mass spectrometr...
Chlamydomonas reinhardtii (C. reinhardtii) N-glycans carry plant typical beta 1,2-core xylose, alpha...
Currently, more than 70% of the commercialized biopharmaceuticals are glycoproteins. The high produc...
Currently, more than 70% of the commercialized biopharmaceuticals are glycoproteins. The high produc...
International audienceIn eukaryots the protein N-glycosylation processes starts in the endoplasmic r...
International audienceIn eukaryots the protein N-glycosylation processes starts in the endoplasmic r...
International audienceIn eukaryots the protein N-glycosylation processes starts in the endoplasmic r...
International audienceIn eukaryots the protein N-glycosylation processes starts in the endoplasmic r...
International audienceNowadays, little information is available regarding the N‐glycosylation pathwa...
International audienceNowadays, little information is available regarding the N‐glycosylation pathwa...
Chlamydomonas reinhardtii (C. reinhardtii) N-glycans carry plant typical beta 1,2-core xylose, alpha...
At present, only little is known about the enzymatic machinery required for N-glycosylation in Chlam...
International audienceChlamydomonas reinhardtii is a green unicellular eukaryotic model organism for...
International audienceChlamydomonas reinhardtii is a green unicellular eukaryotic model organism for...
International audienceChlamydomonas reinhardtii is a green unicellular eukaryotic model organism for...
At present, only little is known about the enzymatic machinery required for N-glycosylation in Chlam...
Chlamydomonas reinhardtii (C. reinhardtii) N-glycans carry plant typical beta 1,2-core xylose, alpha...
Currently, more than 70% of the commercialized biopharmaceuticals are glycoproteins. The high produc...
Currently, more than 70% of the commercialized biopharmaceuticals are glycoproteins. The high produc...
International audienceIn eukaryots the protein N-glycosylation processes starts in the endoplasmic r...
International audienceIn eukaryots the protein N-glycosylation processes starts in the endoplasmic r...
International audienceIn eukaryots the protein N-glycosylation processes starts in the endoplasmic r...
International audienceIn eukaryots the protein N-glycosylation processes starts in the endoplasmic r...
International audienceNowadays, little information is available regarding the N‐glycosylation pathwa...
International audienceNowadays, little information is available regarding the N‐glycosylation pathwa...
Chlamydomonas reinhardtii (C. reinhardtii) N-glycans carry plant typical beta 1,2-core xylose, alpha...
At present, only little is known about the enzymatic machinery required for N-glycosylation in Chlam...
International audienceChlamydomonas reinhardtii is a green unicellular eukaryotic model organism for...
International audienceChlamydomonas reinhardtii is a green unicellular eukaryotic model organism for...
International audienceChlamydomonas reinhardtii is a green unicellular eukaryotic model organism for...
At present, only little is known about the enzymatic machinery required for N-glycosylation in Chlam...
Chlamydomonas reinhardtii (C. reinhardtii) N-glycans carry plant typical beta 1,2-core xylose, alpha...
Currently, more than 70% of the commercialized biopharmaceuticals are glycoproteins. The high produc...
Currently, more than 70% of the commercialized biopharmaceuticals are glycoproteins. The high produc...